New Owner
Teva Pharmaceutical Industries - Labrys Biologics
Teva Pharmaceutical Industries acquires Labrys Biologics
Announced: June 03, 2014
Type: Acquisition
Disposition: Separate Entity
Terms: Cash & Stock
Status: Complete
Amount: $ 825,000,000
Teva Pharmaceutical Industries Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| Aug 03, 2016 |
|
$ 500,000,000 |
| Oct 01, 2015 |
|
$ 2,300,000,000 |
| Sep 25, 2015 |
|
Undisclosed amount |
| Jul 27, 2015 |
|
$ 40,500,000,000 |
| Mar 30, 2015 |
|
$ 3,500,000,000 |
